Naproxen
Shoulder Pain
Konya Beyhekim Training and Research HospitalSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
9 Active assets in the Shoulder Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Triamcinalone Claire Bourgeois | Phase 4 | BB |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Claire Bourgeois | Phase 4 | BB |
Bxcl501 Women's College Hospital | Phase 2 | B |
LIDOCAINE Satasairaala | Phase 2 | B |
ROPIVACAINE Women's College Hospital | Phase 2 | B |
View all 18 →
Same molecule, other indications
Naproxen is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →